Biomea Fusion, Inc. (BMEA)
2.03
+0.12
(+6.28%)
USD |
NASDAQ |
Sep 04, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Shareholders Equity (Quarterly) : 12.14M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.14M |
| March 31, 2026 | 18.72M |
| December 31, 2025 | 29.55M |
| September 30, 2025 | 15.62M |
| June 30, 2025 | 27.51M |
| March 31, 2025 | 28.74M |
| December 31, 2024 | 51.57M |
| September 30, 2024 | 75.97M |
| June 30, 2024 | 103.95M |
| March 31, 2024 | 135.31M |
| December 31, 2023 | 169.24M |
| September 30, 2023 | 199.61M |
| Date | Value |
|---|---|
| June 30, 2023 | 224.30M |
| March 31, 2023 | 83.13M |
| December 31, 2022 | 108.54M |
| September 30, 2022 | 130.64M |
| June 30, 2022 | 150.39M |
| March 31, 2022 | 164.76M |
| December 31, 2021 | 178.78M |
| September 30, 2021 | 191.33M |
| June 30, 2021 | 202.02M |
| March 31, 2021 | 0.221M |
| December 31, 2020 | 5.169M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| REGENXBIO, Inc. | 71.76M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.87M |
| Total Liabilities (Quarterly) | 24.74M |
| Debt to Equity Ratio | 0.0723 |
| Current Ratio | 3.475 |
| Net Debt Paydown Yield | 1.32% |